About Biotrove
Biotrove is a Healthcare company based in Woburn (United States) founded in 1997, and was acquired by Life Technologies in November 2009. Micro- and nano-scale platforms are provided for life science research. Biotrove has raised $39.26 million across 8 funding rounds from investors including NIH, HHS and Fletcher Spaght. The company was acqui-hired. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Genomics. Its legal entity is BioTrove, Inc. Its competitors include PacBio, Omniome and Complete Genomics; 3 of its 3 listed competitors have raised funding.
Company details
Biotrove was founded in 1997 and is located in Woburn, United States. Micro- and nano-scale technology platforms are developed for applications in life sciences and drug discovery research. Operations focus on enabling high-throughput assays, with the flagship Open Array platform supporting up to 3000 simultaneous qPCR tests for genotyping and gene expression analysis in research settings.
- Headquarters Woburn, United States
- Stage Acquired
- SectorsHealthcare
- Website biotrove.com
- Social X
- Acquired by Life Technologies (Nov 2009)
- Legal Name Biotrove, Inc
- Total Equity Funding$39.26M (USD)
in 8 rounds
- Latest Funding Round$13.31M (USD), Series B
Jun 2009
- InvestorsNIH
& 6 more
- Acquired byLife Technologies
(Nov 2009)
Funding Insights of Biotrove
Biotrove has successfully raised a total of $39.26M across 8 strategic funding rounds. The most recent funding activity was a Series B round of $13.31 million completed in June 2009. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $39.26M
- Total Rounds 8
- Last Round Series B — $13.31M
- First Round $5.25M
(Nov 2002)
- Investors Count 6
All 8 funding rounds of Biotrove with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2009 | $13.31M | Series B | – | – | – |
| Sep 2008 | $22.66M | Debt – Convertible | – | – | – |
| Apr 2008 | $473,695 | Grant | – | – | |
| Jul 2007 | Grant | – | – | ||
| Mar 2006 | $7M | Series B | – | – | |
| Apr 2004 | $2.8M | Series B | – | – | |
| Jan 2004 | $10.9M | Series B | – | – | |
| Nov 2002 | $5.25M | Series A | – | – |
7 investors in total: 7 institutional.
Investors in Biotrove
Biotrove has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include NIH, HHS and Fletcher Spaght.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| catalysthealthventures.com | ||||
| zerostage.com | ||||
Support is provided for life science ventures by BioFrontier. | 2001 | biofrontier.co.jp | Tokyo, Japan | |
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
Drug discovery services are provided to the biopharma sector. | 1887 | nih.gov | United States | |
Management consulting and business management services are provided. | 1983 | fletcherspaght.com | Boston, United States | |
Tools and technologies for biotech and biopharma research were supplied. | 1983 | lifetechnologies.com | Carlsbad, United States |
Investor details for Biotrove
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Biotrove
4 dated milestones of Biotrove across 12 years, from founding to its latest funding, stage changes and deals.
- Founded Biotrove is founded.
- Funding First funding round of $5.2M.
- Funding Latest funding round, Series B, of $13.3M.
- Exit Acquired by Life Technologies.
Competitors of Biotrove
Biotrove has 3 listed competitors in our database, 3 of them funded. They include PacBio, Omniome and Complete Genomics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| pacb.com | 2004 | Menlo Park, United States | $395M | 649 | Instrument systems and software for single-molecule real-time sequencing are developed. | |
| omniome.com | 2013 | San Diego, United States | $160.23M | 164 | Genome sequencing platform is provided for clinical diagnostics. | |
| completegenomics.com | 2006 | San Jose, United States | $124.99M | 70 | DNA sequencing platform for human genome analysis is developed. |
Detailed competitors of Biotrove
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Biotrove (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Biotrove
Biotrove was founded in 1997 and raised its 1st funding round 5 years after it was founded.
Biotrove is headquartered in Woburn, United States. It is registered at Woburn, Massachusetts, United States.
Biotrove is a funded company, having raised a total of $39.26M across 8 funding rounds to date. The company's 1st funding round was a Series A of $5.25M, raised on Nov 2002.
Biotrove was founded in 1997 and is located in Woburn, United States. Micro- and nano-scale technology platforms are developed for applications in life sciences and drug discovery research. Operations focus on enabling high-throughput assays, with the flagship Open Array platform supporting up to 3000 simultaneous qPCR tests for genotyping and gene expression analysis in research settings.
Biotrove's top competitors include PacBio, Complete Genomics and Omniome.
Biotrove has 7 investors. Key investors include NIH, HHS, Fletcher Spaght, Life Technologies, and Catalyst Health Ventures.
Biotrove operates through Biotrove, Inc.
Yes. Biotrove was acquired by Life Technologies in November 2009.